Center-Authored Papers

Filters: Author is Magaret, Craig A  [Clear All Filters]
2011
Rolland M, Tovanabutra S, Decamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A et al..  2011.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.. Nature medicine. 17(3):366-71. Abstract
Zhang GL, Ansari HR, Bradley P, Cawley GC, Hertz T, Hu X, Jojic N, Kim Y, Kohlbacher O, Lund O et al..  2011.  Machine learning competition in immunology - Prediction of HLA class I binding peptides.. Journal of immunological methods. 374(1-2):1-4.
Gnanakaran S, Bhattacharya T, Daniels M, Keele BF, Hraber PT, Lapedes AS, Shen T, Gaschen B, Krishnamoorthy M, Li H et al..  2011.  Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections.. PLoS pathogens. 7(9):e1002209. Abstract
2012
Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders-Buell E, Hertz T, Decamp AC, Carrico C, Menis S, Magaret CA et al..  2012.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.. Nature. 490(7420):417-20. Abstract
Cousins MM, Ou S-S, Wawer MJ, Munshaw S, Swan D, Magaret CA, Mullis CE, Serwadda D, Porcella SF, Gray RH et al..  2012.  Comparison of a High-Resolution Melting Assay to Next-Generation Sequencing for Analysis of HIV Diversity.. Journal of clinical microbiology. 50(9):3054-9. Abstract
2014
Gartland AJ, Li S, McNevin J, Tomaras GD, Gottardo R, Janes H, Fong Y, Morris D, Geraghty DE, Kijak GH et al..  2014.  Analysis of HLAA*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.. Journal of virology. Abstract
2015
Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, Decamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M et al..  2015.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.. PLoS computational biology. 11(2):e1003973. Abstract
2016
Edlefsen PT, Birkmann A, Huang M-L, Magaret CA, Kee JJ, Diem K, Goldner T, Timmler B, Stoelben S, Ruebsamen-Schaeff H et al..  2016.  No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.. The Journal of infectious diseases. 214(2):258-264. Abstract
2017
Fiore-Gartland A, Kullman N, Decamp AC, Clenaghan G, Yang W, Magaret CA, Edlefsen PT, Gilbert PB.  2017.  SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials.. Bioinformatics (Oxford, England). 33(15):2386-2388. Abstract
Janes HE, Cohen KW, Frahm N, De Rosa SC, Sanchez B, Hural J, Magaret CA, Karuna S, Bentley C, Gottardo R et al..  2017.  Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial.. The Journal of infectious diseases.